Literature DB >> 18162984

Present techniques for antibody removal.

Gunnar Tydén1, Gunilla Kumlien, Mats Efvergren.   

Abstract

Renal transplantation into a patient with a positive cytotoxic cross-match or with an incompatible blood group inevitably results in acute humoral rejection, unless the HLA or anti-A/B antibodies have been removed before transplantation. Although there are several procedures to remove HLA and anti-A/B antibodies, plasmapheresis and immunoadsorption are the most commonly used. In this report, presently available techniques for antibody removal are briefly reviewed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18162984     DOI: 10.1097/01.tp.0000296102.94695.c0

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  12 in total

1.  ABO-incompatible kidney transplantation.

Authors:  Friedrich Thaiss
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

Review 2.  Benefits and limitations of plasmapheresis in renal diseases: an evidence-based approach.

Authors:  Sanjeev Baweja; Kate Wiggins; Darren Lee; Susan Blair; Margaret Fraenkel; Lawrence P McMahon
Journal:  J Artif Organs       Date:  2010-12-10       Impact factor: 1.731

Review 3.  Strategies to overcome the ABO barrier in kidney transplantation.

Authors:  Georg A Böhmig; Andreas M Farkas; Farsad Eskandary; Thomas Wekerle
Journal:  Nat Rev Nephrol       Date:  2015-09-01       Impact factor: 28.314

Review 4.  ABO incompatible renal transplants: Good or bad?

Authors:  Masaki Muramatsu; Hector Daniel Gonzalez; Roberto Cacciola; Atsushi Aikawa; Magdi M Yaqoob; Carmelo Puliatti
Journal:  World J Transplant       Date:  2014-03-24

5.  Immunoadsorption Column Reuse.

Authors:  Vaibhav Tiwari; Anurag Gupta; Smita Divyaveer; Vinant Bhargava; Manish Malik; Ashwani Gupta; Anil K Bhalla; D S Rana
Journal:  Indian J Nephrol       Date:  2020-11-07

6.  Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders.

Authors:  Adam K Bevan; Sandra Duque; Kevin D Foust; Pablo R Morales; Lyndsey Braun; Leah Schmelzer; Curtis M Chan; Mary McCrate; Louis G Chicoine; Brian D Coley; Paul N Porensky; Stephen J Kolb; Jerry R Mendell; Arthur H M Burghes; Brian K Kaspar
Journal:  Mol Ther       Date:  2011-08-02       Impact factor: 11.454

7.  Short-term results of ABO-incompatible living donor kidney transplantation: comparison with ABO-compatible grafts.

Authors:  Jeong Kye Hwang; Sang Il Kim; Bum Soon Choi; Cheol Woo Yang; Yong Soo Kim; In Sung Moon; Ji Il Kim
Journal:  J Korean Surg Soc       Date:  2011-07-11

8.  ABO Incompatible Kidney Transplantation-Current Status and Uncertainties.

Authors:  Milljae Shin; Sung-Joo Kim
Journal:  J Transplant       Date:  2011-12-10

9.  Antibody-mediated rejection after adult living-donor liver transplantation triggered by positive lymphocyte cross-match combination.

Authors:  Tomohide Hori; Hiroto Egawa; Shinji Uemoto
Journal:  Ann Gastroenterol       Date:  2012

10.  Current progress in ABO-incompatible kidney transplantation.

Authors:  Tai Yeon Koo; Jaeseok Yang
Journal:  Kidney Res Clin Pract       Date:  2015-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.